260
Participants
Start Date
October 14, 2025
Primary Completion Date
April 30, 2027
Study Completion Date
October 31, 2027
PTP-01
Allogeneic human placental tissue particulate (PTP-001) is administered as a single intra-articular injection to the target knee after resuspension with saline.
Placebo control / saline vehicle
The placebo control, physiological saline (0.9% sodium chloride injection, USP), is administered as an intra-articular injection to the target knee.
NOT_YET_RECRUITING
Emeritus Research Sydney, Botany
NOT_YET_RECRUITING
Royal North Shore Hospital, St Leonards
RECRUITING
Genesis Research Services, Broadmeadow
RECRUITING
Momentum Clinical Research Sunshine, St Albans
RECRUITING
Momentum Clinical Research Taringa, Taringa
RECRUITING
Momentum Clinical Research Wellers Hill, Tarragindi
NOT_YET_RECRUITING
University of the Sunshine Coast Clinical Trials, Morayfield, Morayfield
NOT_YET_RECRUITING
University of the Sunshine Coast Clinical Trials, Noosa, Noosaville
NOT_YET_RECRUITING
University of the Sunshine Coast Clinical Trials, Birtinya, Birtinya
Lead Sponsor
Novotech (Australia) Pty Limited
INDUSTRY
Doron Therapeutics Inc.
INDUSTRY